PeptidePicker
Home/Peptides/Triptorelin
ClinicalFDA Approved

Triptorelin

Also known as: Trelstar · Decapeptyl

A potent GnRH agonist used for prostate cancer suppression and as a single-shot HPTA restart protocol after prolonged steroid use.

Dr. Sarah Mitchell

Reviewed by Dr. Sarah Mitchell, PharmD, BCPS

Lead Researcher · 12+ years in peptide therapeutics

Half-Life

~3–5 hours

Typical Dose

100 mcg (single PCT dose) or depot injection (clinical)

Administration

Intramuscular injection

Mechanism of Action

Continuous GnRH receptor stimulation causes initial LH/FSH spike followed by receptor downregulation and complete gonadal suppression.

Key Research Areas

GnRHprostate cancerPCThormone suppression

Frequently Asked Questions

What is Triptorelin?
A potent GnRH agonist used for prostate cancer suppression and as a single-shot HPTA restart protocol after prolonged steroid use.
How does Triptorelin work?
Continuous GnRH receptor stimulation causes initial LH/FSH spike followed by receptor downregulation and complete gonadal suppression.
What is the recommended dosage for Triptorelin?
The typical research dosage is 100 mcg (single PCT dose) or depot injection (clinical), administered via Intramuscular injection. Dosage protocols vary by study and should be determined by a qualified healthcare professional.
What is the half-life of Triptorelin?
The half-life of Triptorelin is approximately ~3–5 hours. This affects dosing frequency and timing in research protocols.
Is Triptorelin FDA approved?
Yes, Triptorelin is FDA approved for specific medical indications. Consult your physician for proper medical guidance.

Research Disclaimer

The information provided about Triptorelin is for educational purposes only and is not intended as medical advice. Always consult a qualified healthcare professional before starting any peptide protocol. Products discussed have not been evaluated by the FDA unless explicitly noted.

Related Peptides in Clinical